The Benefits of Asia-Pacific Clinical Trials For Biotechs
There has been a continued shift of innovation from big pharma companies to biotechs, with the latter paving the ways for advancements in the life sciences industry. At the same pace, the Asia-Pacific (APAC) region has built a reputation as a hub for successful trials. There are unique benefits and challenges to conducting trials in this area, and partnerships with local expert contract research organizations (CROs) can help these companies take advantage of the opportunities. Informa Pharma Intelligence and Novotech surveyed respondents from biopharma companies across geographies to assess their clinical outsourcing needs and understanding of running trials in the APAC region.